Delphi Panel: Next patient populations for manufactured cell-based type 1 diabetes therapy (with / without immunosuppression) (GRA-870)

Summary

Sponsor / funder: Break Through T1D
Program: Not specified
Status: awarded
Period: 2025 – —
Lead unit: Not specified
Amount: $23,000

Award details

Award type: research grant

People

Kirsten Yehl (PI)

None documented.

No related outputs documented yet.

No related publications documented yet.

Verification

Status: Likely current
Notes: Derived from institutional award records.

Sources

DePaul ORS Annual Report, FY2025

Notes

Award metadata compiled from published DePaul research reporting. Listing here records documented activity; it is not an evaluation of the award, the people, or the unit.